查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1375983

止血与组织封闭剂市场规模、份额、趋势、市场分析、按产品、按地区、细分市场预测，2023-2030

Hemostasis And Tissue Sealing Agents Market Size, Share & Trends Market Analysis By Product (Topical Hemostat, Adhesive & Tissue Sealant), By Region (Europe, APAC, North America), And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

止血和组织封闭剂市场的成长和趋势：

Grand View Research, Inc.最新报告显示，预计到2030年，全球止血剂和组织封闭剂市场规模将达到144.7亿美元，2023年至2030年年复合成长率为8.9%。

随着时间的推移，这种药物因其预防出血的能力而受到欢迎。微创技术的快速成长和患者对早期復原的需求预计将在预测期内推动市场成长。据美国美国1.5 亿人患有至少一种可能导致手术甚至死亡的慢性疾病。

根据 CDC 估计，超过 48% 的美国人预计患有慢性病。由于手术数量不断增加，产品需求不断增加，预计该市场将在未来年度实现良好成长。老年人口的增加和慢性病的盛行率也是推动市场的关键因素之一。 2019年12月，强生公司部门Ethicon公司推出了一种止血蛋白喷雾剂，旨在快速有效地控制和封锁微创手术和开放性手术过程中的过度出血，现已上市。

在COVID-19大大流行期间，病毒感染的重症患者往往会出现败血性休克和急性呼吸窘迫症候群（ARDS），需要在ICU进行特殊护理，并导致慢性病，从而导致严重的残疾和不良的长期结果。这些入住 ICU 的患者经常出现凝血异常，显示潜在疾病或器官功能障碍。这是止血和组织密封产品需求不断增长的主要因素之一。

止血和组织封闭剂市场报告亮点

  • 全球手术数量的增加以及该产品在各种手术中的适用性以避免低收缩性休克、血小板减少性疾病、输血和术后併发症推动了市场成长。
  • 2022年，局部止血材料细分市场的销售比重最大，为67.2%。此外，由于与常规治疗结合时止血剂具有成本效益、止血剂吸收快速且容易、组织反应性极小且缺乏抗原性，止血剂将在预测期内上市。预计将在年复合成长率为9.2%。
  • 黏剂和组织密封胶领域预计在预测期内年复合成长率为 8.1%。黏剂和组织密封胶对于控製手术过程中的出血非常重要，并透过黏合和密封受损组织发挥作用。
  • 北美地区主导市场，2022 年收益占有率最大，为 33.1%。

目录

第1章调查方法和范围

第2章执行摘要

第3章止血剂和组织封闭剂市场变数、趋势和范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 普及和成长前景图
  • 产业价值链分析
    • 赎回框架
  • 市场动态
    • 市场驱动因素分析
    • 市场抑制因素分析
  • 止血剂和组织封闭剂市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第4章止血剂和组织封闭剂市场：按产品估计和趋势分析

  • 止血与组织封闭剂市场：重点
  • 止血和组织封闭剂市场：2022 年和 2030 年趋势和市场占有率分析
  • 局部止血剂
  • 黏剂和组织密封剂

第5章止血剂和组织封闭剂市场：区域估计和趋势分析

  • 区域展望
  • 按地区分類的止血剂和组织封闭剂市场：要点
  • 北美洲
    • 2018-2030 年市场估计与预测
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 瑞典
    • 挪威
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 泰国
    • 韩国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东/非洲
    • 沙乌地阿拉伯
    • 南非
    • 阿拉伯聯合大公国
    • 科威特

第6章竞争形势

  • 主要市场参与企业的最新趋势和影响分析
  • 市场参与企业分类
    • Johnson & Johnson
    • Artivion, Inc
    • Pfizer
    • CR Bard
    • B Braun
    • Covidien
    • Advance Medical Solutions Group
    • Smith & Nephew
Product Code: 978-1-68038-597-7

Hemostasis And Tissue Sealing Agents Market Growth & Trends:

The global hemostasis and tissue sealing agents market size is expected to reach USD 14.47 billion by 2030, registering a CAGR of 8.9% from 2023 to 2030, according to a new report by Grand View Research, Inc.. The agents have gained popularity over time due to their ability to prevent blood loss. The rapid growth of minimally invasive technology and the demand for faster recovery by patients are expected to promote market growth over the forecast period. According to the Centers for Disease Control and Prevention (CDC), approximately 150 million of the American population are currently suffering from at least one chronic condition, which leads to surgeries and even mortality at times.

An estimate over the rising incidence was made by the CDC, which concluded that over 48% of the entire American population is expected to suffer from chronic conditions. The market is expected to witness lucrative growth over the next seven years owing to an increase in product demand supported by the rising surgery volumes. Growth in the geriatric population and the prevalence of chronic conditions are also among the key factors driving the market. In December 2019, the Ethicon, a unit of Johnson & Johnson, launched its protein spray for blood-stopping, designed to quickly & efficiently control and seal off excessive bleeding during minimally invasive procedures and open surgeries.

During the COVID-19 pandemic, severe cases among patients infected by the virus have shown the tendency to develop septic shock and Acute Respiratory Distress Syndrome (ARDS), demanding special care in ICU, with residual chronic disability and poor long-term results. Among these patients in the ICU, Coagulopathy has been commonly noticed indicating underlying diseases and organ dysfunction. This has been one of the major contributing factors to the increasing demand for hemostasis & tissue sealing products.

Hemostasis And Tissue Sealing Agents Market Report Highlights:

  • The market growth can be attributed to a rise in the global volume of surgeries and the applicability of the product across a variety of surgeries to avoid the occurrence of hypovolemic shock, thrombocytopenia, blood transfusions, and postoperative complications
  • The topical hemostat segment accounted for the largest revenue share of 67.2% in 2022. In addition, a segment is expected to grow at the fastest CAGR of 9.2% during the forecast period due to its use with conventional treatment to provide cost-efficiency, quick & easy absorbability of the hemostatic agent, minimal tissue reactivity, and non-antigenicity.
  • The adhesive & tissue sealant segment is expected to grow at a CAGR of 8.1% over the forecast period. Adhesives and tissue sealants are crucial in controlling blood loss during surgical procedures and function by binding with and sealing the damaged tissues.
  • North America dominated the market and accounted for the largest revenue share of 33.1% in 2022, owing to the growing prevalence of cardiovascular disorders, diabetes, and cancer within the region.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Product
    • 1.1.2. Regional scope
    • 1.1.3. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type outlook
    • 2.2.2. Material outlook
    • 2.2.3. Application outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Hemostasis & Tissue Sealing Agents Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Industry Value Chain Analysis
    • 3.3.1. Reimbursement framework
  • 3.4. Market Dynamics
    • 3.4.1. Market Driver Analysis
    • 3.4.2. Market Restraint Analysis
  • 3.5. Hemostasis & Tissue Sealing Agents Market Analysis Tools
    • 3.5.1. Industry Analysis - Porter's
      • 3.5.1.1. Supplier power
      • 3.5.1.2. Buyer power
      • 3.5.1.3. Substitution threat
      • 3.5.1.4. Threat of new entrant
      • 3.5.1.5. Competitive rivalry
    • 3.5.2. PESTEL Analysis
      • 3.5.2.1. Political landscape
      • 3.5.2.2. Technological landscape
      • 3.5.2.3. Economic landscape

Chapter 4. Hemostasis & Tissue Sealing Agents Market: Product Estimates & Trend Analysis

  • 4.1. Hemostasis & Tissue Sealing Agents Market: Key Takeaways
  • 4.2. Hemostasis & Tissue Sealing Agents Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Topical Hemostat
    • 4.3.1. Topical Hemostat market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.3.1.1. Active market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.3.2.2. Mechanical market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.3.2.3 Flowable market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. Adhesive & Tissue Sealant
    • 4.4.1. Adhesive & tissue sealant market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.1.1. Synthetic tissue sealant market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.1.2. Natural tissue sealant market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.1.3. Adhesion barrier products market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Hemostasis & Tissue Sealing Agents Market: Regional Estimates & Trend Analysis

  • 5.1. Regional Outlook
  • 5.2. Hemostasis & Tissue Sealing Agents Market by Region: Key Takeaway
  • 5.3. North America
    • 5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.3.2. U.S.
      • 5.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.3.3. Canada
      • 5.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.4. Europe
    • 5.4.1. U.K.
      • 5.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.2. Germany
      • 5.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.3. France
      • 5.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.4. Italy
      • 5.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.5. Spain
      • 5.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.6. Sweden
      • 5.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.7. Norway
      • 5.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.8. Denmark
      • 5.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.5. Asia Pacific
    • 5.5.1. Japan
      • 5.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.2. China
      • 5.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.3. India
      • 5.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.4. Australia
      • 5.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.5. Thailand
      • 5.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.6. South Korea
      • 5.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.6. Latin America
    • 5.6.1. Brazil
      • 5.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.6.2. Mexico
      • 5.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.6.3. Argentina
      • 5.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.7. MEA
    • 5.7.1. Saudi Arabia
      • 5.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.7.2. South Africa
      • 5.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.7.3. UAE
      • 5.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.7.4. Kuwait
      • 5.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 6.2. Market Participant Categorization
    • 6.2.1. Johnson & Johnson
      • 6.2.1.1. Company overview
      • 6.2.1.2. Financial performance
      • 6.2.1.3. Product benchmarking
      • 6.2.1.4. Strategic initiatives
    • 6.2.2. Artivion, Inc
      • 6.2.2.1. Company overview
      • 6.2.2.2. Financial performance
      • 6.2.2.3. Product benchmarking
      • 6.2.2.4. Strategic initiatives
    • 6.2.3. Pfizer
      • 6.2.3.1. Company overview
      • 6.2.3.2. Financial performance
      • 6.2.3.3. Product benchmarking
      • 6.2.3.4. Strategic initiatives
    • 6.2.4. C R Bard
      • 6.2.4.1. Company overview
      • 6.2.4.2. Financial performance
      • 6.2.4.3. Product benchmarking
      • 6.2.4.4. Strategic initiatives
    • 6.2.5. B Braun
      • 6.2.5.1. Company overview
      • 6.2.5.2. Financial performance
      • 6.2.5.3. Product benchmarking
      • 6.2.5.4. Strategic initiatives
    • 6.2.6. Covidien
      • 6.2.6.1. Company overview
      • 6.2.6.2. Financial performance
      • 6.2.6.3. Product benchmarking
      • 6.2.6.4. Strategic initiatives
    • 6.2.7. Advance Medical Solutions Group
      • 6.2.7.1. Company overview
      • 6.2.7.2. Financial performance
      • 6.2.7.3. Product benchmarking
      • 6.2.7.4. Strategic initiatives
    • 6.2.8. Smith & Nephew
      • 6.2.8.1. Company overview
      • 6.2.8.2. Financial performance
      • 6.2.8.3. Product benchmarking
      • 6.2.8.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 North America hemostasis & tissue sealing agents market, by product, 2018 - 2030 (USD Million)
  • Table 3 North America hemostasis & tissue sealing agents market, by region, 2018 - 2030 (USD Million)
  • Table 4 U.S. hemostasis & tissue sealing agents market, by product, 2018 - 2030 (USD Million)
  • Table 5 Canada hemostasis & tissue sealing agents market, by product, 2018 - 2030 (USD Million)
  • Table 6 Europe hemostasis & tissue sealing agents market, by product, 2018 - 2030 (USD Million)
  • Table 7 Europe hemostasis & tissue sealing agents market, by region, 2018 - 2030 (USD Million)
  • Table 8 Germany hemostasis & tissue sealing agents market, by product, 2018 - 2030 (USD Million)
  • Table 9 UK hemostasis & tissue sealing agents market, by product, 2018 - 2030 (USD Million)
  • Table 10 France hemostasis & tissue sealing agents market, by product, 2018 - 2030 (USD Million)
  • Table 11 Italy hemostasis & tissue sealing agents market, by product, 2018 - 2030 (USD Million)
  • Table 12 Spain hemostasis & tissue sealing agents market, by product, 2018 - 2030 (USD Million)
  • Table 13 Sweden hemostasis & tissue sealing agents market, by product, 2018 - 2030 (USD Million)
  • Table 14 Norway hemostasis & tissue sealing agents market, by product, 2018 - 2030 (USD Million)
  • Table 15 Denmark hemostasis & tissue sealing agents market, by product, 2018 - 2030 (USD Million)
  • Table 16 Asia Pacific hemostasis & tissue sealing agents market, by product, 2018 - 2030 (USD Million)
  • Table 17 Asia Pacific hemostasis & tissue sealing agents market, by region, 2018 - 2030 (USD Million)
  • Table 18 China hemostasis & tissue sealing agents market, by product, 2018 - 2030 (USD Million)
  • Table 19 Japan hemostasis & tissue sealing agents market, by product, 2018 - 2030 (USD Million)
  • Table 20 India hemostasis & tissue sealing agents market, by product, 2018 - 2030 (USD Million)
  • Table 21 Australia hemostasis & tissue sealing agents market, by product, 2018 - 2030 (USD Million)
  • Table 22 Thailand hemostasis & tissue sealing agents market, by product, 2018 - 2030 (USD Million)
  • Table 23 South Korea hemostasis & tissue sealing agents market, by product, 2018 - 2030 (USD Million)
  • Table 24 Latin America hemostasis & tissue sealing agents market, by product, 2018 - 2030 (USD Million)
  • Table 25 Latin America hemostasis & tissue sealing agents market, by region, 2018 - 2030 (USD Million)
  • Table 26 Brazil hemostasis & tissue sealing agents market, by product, 2018 - 2030 (USD Million)
  • Table 27 Mexico hemostasis & tissue sealing agents market, by product, 2018 - 2030 (USD Million)
  • Table 28 Argentina hemostasis & tissue sealing agents market, by product, 2018 - 2030 (USD Million)
  • Table 29 Middle East and Africa hemostasis & tissue sealing agents market, by product, 2018 - 2030 (USD Million)
  • Table 30 Middle East and Africa hemostasis & tissue sealing agents market, by region, 2018 - 2030 (USD Million)
  • Table 31 South Africa hemostasis & tissue sealing agents market, by product, 2018 - 2030 (USD Million)
  • Table 32 Saudi Arabia hemostasis & tissue sealing agents market, by product, 2018 - 2030 (USD Million)
  • Table 33 UAE hemostasis & tissue sealing agents market, by product, 2018 - 2030 (USD Million)
  • Table 34 Kuwait hemostasis & tissue sealing agents market, by product, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Hemostasis & tissue sealing agents: Market outlook
  • Fig. 9 Hemostasis & tissue sealing agents: Competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Hemostasis & tissue sealing agents market driver impact
  • Fig. 15 Hemostasis & tissue sealing agents market restraint impact
  • Fig. 16 Hemostasis & Tissue Sealing Agents Market Strategic Initiatives Analysis
  • Fig. 17 Hemostasis & tissue sealing agents market: Product movement analysis
  • Fig. 18 Hemostasis & tissue sealing agents market: Product outlook and key takeaways
  • Fig. 19 Topical hemostat market estimates and forecasts, 2018 - 2030
  • Fig. 20 Active market estimates and forecasts, 2018 - 2030
  • Fig. 21 Mechanical market estimates and forecasts, 2018 - 2030
  • Fig. 22 Flowable market estimates and forecasts, 2018 - 2030
  • Fig. 23 Adhesives & tissue sealant market estimates and forecasts, 2018 - 2030
  • Fig. 24 Synthetic tissue sealant market estimates and forecasts, 2018 - 2030
  • Fig. 25 Natural tissue sealant market estimates and forecasts, 2018 - 2030
  • Fig. 26 Adhesion barrier products market estimates and forecasts, 2018 - 2030
  • Fig. 27 Global Hemostasis & tissue sealing agents market: Regional movement analysis
  • Fig. 28 Global Hemostasis & tissue sealing agents market: Regional outlook and key takeaways
  • Fig. 29 North America market estimates and forecasts, 2018 - 2030
  • Fig. 30 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 31 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 32 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 33 U.K. market estimates and forecasts, 2018 - 2030
  • Fig. 34 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 35 France market estimates and forecasts, 2018 - 2030
  • Fig. 36 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 37 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 38 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 39 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 40 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 41 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 42 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 43 China market estimates and forecasts, 2018 - 2030
  • Fig. 44 India market estimates and forecasts, 2018 - 2030
  • Fig. 45 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 46 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 47 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 48 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 49 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 50 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 51 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 52 Middle East and Africa. market estimates and forecasts, 2018 - 2030
  • Fig. 53 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 54 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 55 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 56 Kuwait market estimates and forecasts, 2018 - 2030